chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash on the shoulder where she got vaccinated; rash was itchy, small, red, raised bumps like Eczema; rash was itchy, small, red, raised bumps like Eczema; rash was itchy, small, red, raised bumps like Eczema; rash was spreading like a small circular patch; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 21-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9264, expiration date not reported), dose 1 via an unspecified route of administration, administered in left arm on 19Feb2021, 14:45 (age at the time of vaccination 21-year-old) as 1st dose, single for covid-19 immunization. The patient medical history included, Wolff-Parkinson-white syndrome, Eczema (arms and back of legs), mental health conditions from an unknown date and unknown if ongoing. The patient concomitant medications in two weeks included Lisdexamfetamine mesilate (VYVANSE), Oxcarbazepine (TRILEPTAL), Escitalopram oxalate (LEXAPRO), Trazodone (TRAZODONE). The patient previously took Abilify and experienced Drug hypersensitivity, patient reported that when she first started taking Trileptal, she also had a rash reaction, but not as widespread as this. Patient usually only get eczema on the inside of my arms and back of my legs too. But patient had different reaction with BNT162B2. On 22Feb2021 at 09:00 after the vaccination the patient when she woke up she started to develop a rash on the shoulder where she got vaccinated. It was also on patient left collar a small patch. The rash was itchy, small, red, raised bumps like Eczema. On Wednesday the rash was spread to other parts of the body like chin, on thigh near groin, thigh near knee, further down left arm, and tonight stomach. The rash was spreading like a small circular patch. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not had COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. No treatment was received for the event. The events were not recovered at the time of report.   Follow-up attempts are completed. No further information is expected
Received her second dose Pfizer vaccine (LOT#: EW0185 EXP: 8/2021) at 1450 on 5/25/21. Patient alerted EMT at 1514 about 24 minutes after her vaccine. Patient stated that she felt heat radiating from her vaccine site to the right side of her face and right cheek region. Patient stated that the heat turned into numbness throughout the same region. Patient was given water. Patient was able to swallow water without any difficulty. Patient denied any SOB. EMT took patients vitals at 1516. BP: 119/98, pulse: 86, O2: 97%. PHN asked patient to stay an extra 30 minutes for further observation. Patient agreed to stay an extra 30 minutes. PHN offered patient Diphenhydramine 2x 25mg/mL. Patient agreed to take Diphenhydramine. PHN gave Diphenhydramine to patient at 1523. EMT reassessed and retook patient vital signs at 1528. BP: 130/90, pulse: 64, O2: 96%. Patient stated that her symptoms had not changed and were still similar. EMT reassessed and retook patient vital signs at 1533. BP: 120/83, pulse: 86, O2: 96%. Patient stated that her symptoms decreased but were still present. EMT reassessed and retook vital signs at 1538. BP: 110/81, pulse: 87, O2: 95%. Patient stated that she still felt numbness throughout her right cheek and right arm but no longer felt numbness in her neck or throat. EMT reassessed and retook patient vital signs at 1553. BP: 115/82, pulse: 85, O2: 95%. Patient stated that her symptoms were only present in her upper right arm and the numbing had decreased. Patient was talking to EMT throughout observation time. Patient had completed observation time. Patient was reassessed by EMT. Patient stated that she was feeling a lot better. Patient was educated on worsening signs and symptoms of the vaccine and when to call EMS or go to urgent care/emergency room. Patient verbalized understanding of education. Patient walked out of vaccination site at 1555 unassisted and with a steady gait.
I received a flu vaccine on Thursday. Late Friday I began to feel very, very fatigued. This lasted all weekend and to a lesser degree for two more weeks. During this time I developed pain in the back of both of my lower legs. As of Nov. 3 I am still experiencing the pain all day and all night.
40 yo male with erythema and edema from middle of (R) arm down past elbow with total area >120mm. Pt c/o local paresthesia and pain. Body wide aches and joint pain. Pt treated with Allegra and 5 days of Prednisone.
Fever; Headache; Weakness; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), FATIGUE (Very tired), PYREXIA (Fever) and HEADACHE (Headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.     On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ASTHENIA (Weakness) and FATIGUE (Very tired). On 18-Feb-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, ASTHENIA (Weakness), FATIGUE (Very tired), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were provided by reporter  Treatment details was unknown.
Tinnitus.  I had a very mild case prior to last week due to side effects of migraine medications in the past; unless in absolute silence, I usually forgot I had it.  The volume has increased by at least 3 or 4 times; it is now shrill and ever-present.
Seizure like events; Began sputtering; My shoulder and neck seized up; Eyes rolled back in her head and she had no control over it; Did not remember some of it; Confused; Unable to focus with her eyes; Extreme fatigue; Walking is unsteady; This is a spontaneous report from a contactable consumer (the patient). A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: 59267-1000-03), via an unspecified route of administration, administered in left arm on 24Mar2021 16:45 as single dose for COVID-19 immunization. Medical history included asthma, bronchitis, anxiety, allergy to Aspirin, NSAIDs, agave, soy, and dairy. The patient has no history of COVID prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not COVID tested post vaccination. Concomitant medications included venlafaxine and progesterone taken for an unspecified indication. On 24Mar2021, 19:30, the patient experienced seizure like events. She began sputtering, her shoulder and neck seized up, eyes rolled back in her head and she had no control over it and did not remember some of it. It happened twice in a row. She had been confused, unable to focus with her eyes, extreme fatigue, and her walking was unsteady. The adverse event resulted in Emergency room/department or urgent care. The patient received treatment for the events. The patient was requested for testing and referral for neurologist for MRI. The patient has not recovered from the events.  Follow up attempts are possible. Further information is expected.
Pt vax w/ hepta B on 04Dec90; pt exp drawing sensation in right eye, h/a, tightness on scalp, soapy taste in mouth, spots in right eye.
Information has been received from a pharmacist concerning a 12 year old male who on 19-AUG-2010 was inadvertently subcutaneously vaccinated with a dose of ZOSTAVAX (Merck) (lot # 664636/0874Y, exp. 20-DEC-2010) instead of VARIVAX (Merck) (human error, not PQC). The pharmacist did not know which dose in the series this administration. No adverse effects reported. Additional information is not expected.
Initial report received from a consumer on 03 October 2013. A female patient of unspecified age, had received Flu vaccine from unknown manufacturer (batch number, dose number, route and anatomical site of vaccination were not reported) on an unspecified in 2009. Patient had received a Flu vaccine in 1979 and following vaccination had very red and swollen arm. Patient is allergic to Thimerosal. Patient's concomitant medications were not reported. On an unspecified date after receiving Flu vaccine with preservative, the patient had "the shakes", red arm with swelling of football size. Patient had received several flu vaccines since 2009, all of which did not contain thimerosal, and not had any reactions after any of those flu vaccines. Corrective treatments and laboratory investigations were not reported. On an unspecified date, the patient had recovered from the events. Document Held by Sender: None.
This spontaneous report was received from a pharmacist concerning a 59 year old male patient with no pertinent medical history and no drug reactions/allergies. It was reported that, on 19-SEP-2012, the patient might had vaccinated with a dose of PNEUMOVAX 23, intravenously during hospitalization (patient was in hospital due to an unspecified reason). Lot number and expiry date was reported as 0217AE and 22-AUG-2013 respectively. No concomitant medications were reported. Subsequently on an unknown date in September 2012, the patient experienced a slight rise in temperature. Hospitalization was not prolonged. On an unknown date in September 2012, the event slight rise in temperature was resolved. The relatedness for slight rise in temperature was unknown for PNEUMOVAX 23. The patient sought unspecified medical attention. Additional information has been requested.
Patient reports light headed, tingle left finger, pain in stomach, left side of body hurts, headache, and slurred words started two days after vaccination.
1/22 ? Received second dose of vaccine 1/23-1/25 ? started having LLQ abdominal, flank, and back pain.  The pain was isolated, sharp in nature and rated 7/10.  No rash or blistering in the area. 1/25 ? Contacted primary care physician and referred to medical facility for work up.  Ruled out kidney stone.  Abdominal CT scan negative.  Treated with Torodal and Dilaudid with minimal relief. Discharged dx of muscle spasm and rx for muscle relaxants.  1/26 ? Follow up appointment with primary care physician.  Added NSAIDS for ongoing pain.  1/27 ? Represented to ETC for ongoing LLQ abdominal, flank, and back pain.  Noted constipation.  KUB(kidney, ureter, and bladder) showed ileus.  1/28 ? Follow up appointment with primary care physician.  Started on gabapentin 100mg TID for ongoing pain. 2/3 ? LL abdominal bulge noted (16cm x 10cm).  Contacted primary care physician and referred back to hospital.  Repeat KUB(kidney, ureter, and bladder) and CT scan are negative.  2/4 ? Follow up appointment with primary care physician.  MRI of lumbar spine ordered. 2/10 ? Appointment with colorectal surgeon.  Appreciated continued bulge.  Recommended follow up appointment with hernia surgeon. 2/11 ? Appointment with hernia surgeon.  Noted that the bulge decompresses when laying flat.  Abdominal ultrasound ordered to rule out spigelian hernia. 2/12 ? Ultrasound negative for any kind of defect.  Lumbar MRI performed. 2/17 ? follow up appointment with hernia surgeon.  Based upon everything they believe that this is a pseudohernia likely caused by the COVID vaccine and possible irritation of HZ virus.  Continued to not show any rash or blistering.  Continue with gabapentin and added acyclovir."
pt devel redness, edema, warmth & pain shooting up shoulder & down arm;erythema from 15-25mm;
Please note that this inquiry is about an influenza vaccine which I received a year ago on November 6, 2015. Unfortunately, I did not known about VAERS until recently or I would have written earlier. I am a registered nurse, and have received the influenza vaccine yearly for about 30 years without any other reaction than a sore arm for a few days. It is time to get another influenza vaccine, but because of what happened after last year's vaccination, I am afraid to get another shot. For a few days after the vaccine was given, I had a dull headache which was followed by light headedness. Then the following symptoms gradually occurred. I felt as if my brain was irritated or overactive. I could not watch TV or work on the computer because it seemed to irritate my brain. I could not listen to music because that also bothered my brain and even the ticking of the clock was troublesome. Sudden noises seemed to startle my brain. I could not read for more than 1/2 hour when I normally could read a whole day and I did not have patience to do word puzzles. When I was going to sleep, I would sometimes see flashes of light and I experienced buzzing sounds in my brain. Most of the symptoms gradually went away. It took about 4-5 months with the hearing sensitivity lasting the longest. At this time, I do not have any symptoms except for the buzzing sounds which is very minimal and may be tinnitus. I spoke with my family physician and she thought it was possible that it could be a reaction to the influenza vaccine although she said that it was not cited in the literature. I would appreciate hearing from you, particularly if you think the symptoms could have been a reaction to the vaccine and if it is likely to occur again with another influenza vaccination. Thank you.
Patient reports a continuous headache which began following first dose of COVID vaccination which was administered at a state run facility located at the mall in town
pt recv vax & 27AUG97 pt devel a fever of 102 & gen measles-like rash;it was reported that these sx had persisted for 3 days;
Language barrier prevented nurse and recipient not picking up that vaccine being given was Pfizer and recipent should be receiving Moderna Vaccine
positive COVID-19; runny nose; loss of smell; Sore arm; A spontaneous report was received from a pharmacist concerning a 39-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, runny nose, a little loss of smell, tested positive for Covid-19.  The patient's medical history was not provided. No relevant concomitant medications were reported. Other unspecified medications included Nexium for unknown use.  On 11 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 11 Jan 2021, the patient experienced the events sore arm . On 25 Jan 2021, the patient experienced the events runny nose and a little loss of smell. On 29 Jan 2021, the patient reported tested positive for Covid-19.  Treatment for the events was not reported. Action taken with mRNA-1273 in response to the events was not reported.   On 2 Feb 2021, the outcome of the events sore arm, runny nose and loss of smell were reported to be resolved. On 2 Feb 2021 the outcome of the event tested positive for Covid-19 was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Based on mechanism of action of mRNA -1273 vaccine, the event COVID-19 is assessed as unlikely related to mRNA-1273
6/17/21 Sudden onset segment elevated myocardial infarction.  Required double bypass.  Calcium score from 2017 was 0%.  Per surgeon, cause was unique as all other arteries were pristine.
BOOSTRIX was given to a 4 year old boy; This non-serious case was reported by a medical representative via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced inappropriate age at vaccine administration (Verbatim: BOOSTRIX was given to a 4 year old boy). The outcome of the inappropriate age at vaccine administration was unknown.   Additional Information: GSK Receipt Date: 08-AUG-2023. Office Manager for clinic reported that Boostrix was given to a 4-year old boy, which led to inappropriate age at vaccine administration. The reporter consented to follow up.
Became tired around 8pm, followed by chills, fever 101.8, sweats(taken around 12:30am), weakness, joint pain, and nausea. The fever and chills lasted around 5 hours. The following day I was weak in my hands and joints were sore.   I am a breastfeeding mom and my son broke out in a rash the following day. He was brought to the doctor. No data to show a correlation though.
The Adacel 06855AA was expired on 25 Nov 2022. There was no adverse advent and no untoward symptoms, Patient was advised he would need to be revaccinated.
This spontaneous prospective pregnancy report as received from a nurse practitioner refers to a female patient of unknown age. It was reported that the patient was pregnant, four week gestation with last menstrual period (LMP) approximately on: 06-JAN-2015 and estimated date of delivery (EDD) on 13-OCT-2015. On 04-FEB-2015 the patient was vaccinated with MMR II (dose, route of administration, lot number and expiration date were not reported). No adverse effect was noted. Additional information has been requested.
devel a rash-raised w/some whelps @ site of DTP on lt thigh; rash on trunk & arms; no temp some itching around neck; no resp distress;
Indigestion; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA, HEADACHE, and NAUSEA in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, GABAPENTIN and LISINOPRIL for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced DYSPEPSIA, HEADACHE, and NAUSEA. The patient was treated with TYLENOL ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DYSPEPSIA, HEADACHE, and NAUSEA outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.
Very red and dry eyes, looking at computer screen discomforting, minor headaches, eyedrops for antihistamine. 08/03/2021 ongoing. Discomfort has improved
Fever, Chronic arm pain near injection site all the way down, chronic headache, right arm that was injected swollen with decreased  range of motion because pain is severe
mucous membrane pemphigoid; retinal detachment of the left eye; retinal tear in the right eye; widespread, plaque-like rash; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 08-OCT-2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (route of administration, anatomical location, lot# and expiration date were not provided) vaccine for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered a widespread, plaque-like rash. The patient then suffered blistering lesions causing pain and bleeding which was diagnosed as mucous membrane pemphigoid. In addition, the patient suffered and ultimately was diagnosed with retinal detachment of the left eye and retinal tear in the right eye. As a direct and proximate result of Company's defective zoster vaccine live (ZOSTAVAX), the patient's symptoms resulted in physical limitations not present prior to using Company's product. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Company's conduct, the patient suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered. The reporter considered all events to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the events of pemphigoid, retinal tear and retinal detachment were considered to be medially significant. All events were additionally considered to be disabling.
Injection administered at 12:30 on 10/03/21.  Numbness down arm to finger tips.  Resolved at 6 PM same evening.  Injection site warm to touch.  Low grade back pain began on Tuesday.  Injection site still warm to touch.  Large area of swelling began at injection site.  Friday evening at 4:30 Pm began urinary symptoms.  Pain upon urination.  Severe flank pain on left.  Bowels became explosive.  Severe abdominal pain.  Chest pain began approximately 8 PM 10/8.  Midnight Friday- Saturday AM developed fever, severe dizziness, nausea, severe headache.  Chest pain continued.  Lethargy on Saturday 10/09.  Sunday 10/10/21 the injections site became red and hot with a rash.  Skin became tight and swollen.  Redness remains to arm 10/12/21
fever of 103.6 for two days, chills, sweats, convulsions, intense headache, weak, no apatite for two days, intense kidney pain for four days, cough, runny nose
site where flu vax was given deltoid 3x4" red area, warm to touch, raised area; area reddness & induration resolved
Pain and numbness of the left arm, Pressure under the left eye. Random tremors. tremors last about 15 mins. Blurry vision
Fever developed first the same day as the vaccines, to 101. The fever persisted for 4 days.  The day following vaccination he became very fatigued and this lasted for over a week.  Finally, he intermittently complained of neck, back and knee pain but there were no signs of arthiritis.  These symptoms also were intermittent for almost a week.  All symptoms self resolved eventually.
Upper shoulder, back, and arm soreness, along C7 dermatones; beginning on same day as Pfizer vaccination booster and continuing through present day (1/5/2022).
Left internal carotid artery occlusion; This is a spontaneous report from a contactable physician. A 30-year-old male patient received bnt162b2, via an unspecified route of administration on 20Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced left internal carotid artery occlusion on 04Apr2021. The event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. It was unknown if treatment received. The outcome of the event was unknown.  Information on the lot/batch number has been requested.